15 August 2023
Change in substantial holding
14 August 2023
Starpharma to receive A$6.5M from Mundipharma and rights to VivaGel® BV
2 August 2023
Change in substantial holding
31 July 2023
Quarterly Activities Report & Appendix 4C
31 July 2023
Partnered program update
28 July 2023
Trading Halt Announcement - Partnered Program
26 July 2023
Starpharma partners with UQ to advance DEP® radio pipeline
21 July 2023
DEP® HER2-radiodiagnostic shows imaging benefits
27 June 2023
Clinical trial update
23 June 2023
Life Sciences Investor Presentation
22 June 2023
SPL Investor Presentation - OTCQX
22 June 2023
Starpharma to present at Life Sciences Investor Forum
14 June 2023
AZD0466 clinical data presented by AstraZeneca at EHA Congress
9 June 2023
Starpharma CEO to retire in 2024
5 June 2023
VIRALEZE™ Nasal Spray Approved in Malaysia
28 April 2023
Quarterly Activities Report & Appendix 4C
26 April 2023
HER2-targeted DEP® SN-38 ADC outperforms in HER2+ human cancer model
20 April 2023
AZD0466 active in small cell lung cancer patient models
17 April 2023
DEP® cabazitaxel Phase 2 clinical trial completes enrolment and treatment
22 March 2023
Starpharma presents at ASX Small and Mid-Cap Conference

Investor Relations

For general questions about Starpharma Holdings Limited, please contact us at:

T: +61 3 8532 2700
E: investor.relations@starpharma.com


This website is intended for people seeking information about Starpharma for investment and business purposes. This website contains information about products that may not be available, or approved, in all countries, or may be available under different trademarks, or for different indications. Individuals seeking information about a Starpharma product should visit the relevant product website in their country of residence or consult a healthcare provider. Nothing contained on this site should be considered a solicitation, promotion, or advertisement for any product, including those under development. Any information on this site is not intended to provide medical advice nor should be used as a substitute for the advice provided by a doctor or other healthcare provider.